Glazer Capital LLC’s EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share EQHA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-20,539
Closed -$7K 840
2022
Q1
$7K Sell
20,539
-436,537
-96% -$159K ﹤0.01% 526
2021
Q4
$238K Buy
+457,076
New +$260K 0.01% 580

Other funds holding EQHA.WS

Glazer Capital LLC's EQHA.WS Position: Q2 2022 in Review

Glazer Capital LLC sold out of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) in Q2 2022, closing a stake of 20,539 shares — an estimated $7K sold.

Glazer Capital LLC first reported a position in EQHA.WS in Q4 2021 and held it in 2 quarters. The position peaked at $238K in Q4 2021. 61 funds tracked by Wall St. Rank hold EQHA.WS as of Q2 2022.

  • Glazer Capital LLC reported no remaining EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q2 2022 after selling out during the quarter.
  • Glazer Capital LLC sold 20,539 EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q2 2022, an estimated $7K.
  • Glazer Capital LLC first reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q4 2021 and held it in 2 quarters.
  • Glazer Capital LLC's EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $238K in Q4 2021.
  • 61 funds tracked by Wall St. Rank held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q2 2022.

Based on Glazer Capital LLC's 13F filing for Q2 2022, filed 15 Aug 2022.